Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cantor Equity Partners, Inc. (CEPO) vs Drugs Made In America Acquisition Corp. (DMAA)

Cantor Equity Partners, Inc. and Drugs Made In America Acquisition Corp. are both Shell Companies companies. Cantor Equity Partners, Inc. and Drugs Made In America Acquisition Corp. are of similar size ($274.5M and $263.4M).

Valuation

Metric CEPO DMAA Shell Companies median
P/E n/m — 39.97
P/S n/m — 12.19
P/B n/m — 2.01
Price to free cash flow n/m — 28.89
EV/EBITDA n/m — —
EV/Sales n/m — —
Earnings yield (2.69%) — 1.63%
Free cash flow yield 0.00% — (0.79%)

Profitability

Metric CEPO DMAA Shell Companies median
Gross margin — — 71.01%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity 68.61% — 1.91%
Return on assets (3.49%) — 2.03%
Return on invested capital 0.00% — 0.00%

Growth

Metric CEPO DMAA Shell Companies median
Revenue growth (TTM) — — —
EPS growth (last fiscal year) (1,497.63%) — —
Revenue growth, 5-year CAGR — — —
Net income growth, 5-year CAGR — — 0.00%

Health

Metric CEPO DMAA Shell Companies median
Debt to equity 0.00 — 0.00
Current ratio 0.11 — 0.08
Net debt to EBITDA 0.03 — 0.06

Dividend

Metric CEPO DMAA Shell Companies median
Dividend yield — — —
Payout ratio — — 0.00

Size

Metric CEPO DMAA Shell Companies median
Market cap 274.51m 263.40m 154.76m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack